Your browser doesn't support javascript.
loading
The Prevalence and Factors Associated with Coronary Heart Disease in Patients with Gout.
Markelova, E L; Eliseev, M S; Il'inykh, E V; Glukhova, S I; Nasonov, E L.
Afiliação
  • Markelova EL; Moscow Regional Research and Clinical Institute (MONIKI), Moscow, Russia. evgenia-im@yandex.ru.
  • Eliseev MS; Nasonova Research Institute of Rheumatology, Moscow, Russia.
  • Il'inykh EV; Nasonova Research Institute of Rheumatology, Moscow, Russia.
  • Glukhova SI; Nasonova Research Institute of Rheumatology, Moscow, Russia.
  • Nasonov EL; Nasonova Research Institute of Rheumatology, Moscow, Russia.
Dokl Biochem Biophys ; 517(1): 269-276, 2024 Aug.
Article em En | MEDLINE | ID: mdl-39002009
ABSTRACT
Gout is associated with increased risk of cardiovascular disease (CVD) morbidity and mortality. Therefore, an association between coronary heart disease (CHD) and gout deserves careful examination.

AIM:

. The aim of this study was to determine the prevalence of CHD and factors associated with CHD in patients (pts) with gout. MATERIALS AND

METHODS:

. The study involved 286 male patients with gout, age 51.2 [42.8; 59.4] years (ys), disease duration 6.2 [3.8; 12.1] ys. All patients underwent standard clinical examination screening traditional risk factors (TRFs) of CVDs. We estimated the adjusted odds ratio (OR) and 95% confidence interval (95% CI).

RESULTS:

. CHD was found in 111 out of the 286 pts (38.8%), MI had a history in 29.7%. Compared to individuals with CHD, participants without CHD were older (56.7[52.1; 61.1] vs 46.2[40.6; 53.4] ys), had longer duration of gout (9.3[4.7; 15.1] vs 5.6[3.3; 9.7] ys) (for all p < 0.05). Abdominal obesity (OR, 3.6; 95% CI, 1.2-10.9), family history of CHD (OR, 2.2; 95% CI, 1.3-3.7), disease duration of gout more 10 ys (OR, 2.8; 95% CI, 1.6-4.7), age of gout onset < 35 ys (OR, 5.5; 95% CI, 2.6-11.7), intraosseous tophi (OR, 3.03; 95% CI, 1.8-5.01), nephrolithiasis (OR, 1.7; 95% CI, 1.04-3.04), renal failure (OR, 5.6; 95% CI, 2.7-11.4), serum total cholesterol (TC), (OR, 1.6; 95% CI, 1.0-2.8), serum creatinine (OR, 2.5; 95% CI, 1.2-5.1), increased the risk for CHD in patients with a gout.

CONCLUSIONS:

. The prevalence of CHD was 38.8% among individuals with gout (one-third of patients had a history of MI 29.7%). Our study showed that both TRFs of CVD and the severity of gout and a history of renal failure contribute to the development of CHD in patients with gout.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença das Coronárias / Gota Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença das Coronárias / Gota Idioma: En Ano de publicação: 2024 Tipo de documento: Article